Literature DB >> 9714550

Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion.

B C Dash1, T A Harikrishnan, R Goila, S Shahi, H Unwalla, S Husain, A C Banerjea.   

Abstract

With the ultimate aim of developing an effective antiviral strategy against HIV-1, a mono-DNA enzyme possessing the 10-23 catalytic motif [Santoro and Joyce (1997) Proc. Natl. Acad. Sci. USA 94, 4264-4266] was synthesized against the HIV-1 envelope gene. We tested the in vitro cleavage efficiency of the 178 bp long truncated HIV-1 Env transcript by DNA enzyme 6339. Protein independent and Mg2+ dependent specific cleavage products were obtained. As soon as 5 min after mixing equimolar concentrations of DNA enzyme and substrate RNA, more than 50% cleavage was observed which increased steadily over a period of 4 h. Very little cleavage was obtained at 1 mM MgCl2 concentration which improved significantly when the concentration of MgCl2 was increased up to 20 mM. Specific inhibition of cell membrane fusion caused by the interaction of gp160 and CD4 in HeLa cells was observed when the above DNA enzyme was used. Thus, these chemically synthesized DNA enzymes could prove to be very useful for in vivo application.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714550     DOI: 10.1016/s0014-5793(98)00799-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Inhibition of hepatitis B virus X gene expression by novel DNA enzymes.

Authors:  R Goila; A C Banerjea
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 2.  Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

Authors:  L M Khachigian
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

3.  In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.

Authors:  B Sriram; A C Banerjea
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Ribozymes that cleave reovirus genome segment S1 also protect cells from pathogenesis caused by reovirus infection.

Authors:  S Shahi; G K Shanmugasundaram; A C Banerjea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

5.  Genetic factors for aids progression: Analyses of HIV-1 resistant genes in India and therapeutic potentials of novel catalytic RNA and DNA molecules.

Authors:  Samitabh Chakraborti; Akhil C Banerjea
Journal:  Indian J Clin Biochem       Date:  2002-07

6.  Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.

Authors:  H Unwalla; A C Banerjea
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

7.  An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV).

Authors:  Shuwen Wu; Junqiang Xu; Jiangxia Liu; Xuan Yan; Xiaodong Zhu; Gengfu Xiao; Lunquan Sun; Po Tien
Journal:  J Gene Med       Date:  2007-12       Impact factor: 4.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.